Company Encyclopedia
View More
name
Prenetics Global
PRE.US
Prenetics Global Limited, a health sciences company, focuses on advancing consumer health in Hong Kong, the United States, and internationally. It sells health and wellness products under the IM8 brand name; and provides fulfillment and distribution services for sports nutrition products under the Europa brand. The company is also involved in the operation of CircleDNA, a consumer genetic testing brand that uses next-generation sequencing (NGS) technology to provide comprehensive insights into health, wellness, and genetic predispositions. Prenetics Global Limited was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.
385.97 B
PRE.USMarket value -Rank by Market Cap -/-

Financial Score

27/12/2025 Update
C
Health Care ServicesIndustry
Industry Ranking42/82
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreD
    • ROE-28.18%E
    • Profit Margin-60.39%E
    • Gross Margin59.54%A
  • Growth ScoreB
    • Revenue YoY201.54%A
    • Net Profit YoY0.77%C
    • Total Assets YoY-16.65%E
    • Net Assets YoY-10.49%D
  • Cash ScoreB
    • Cash Flow Margin-165.58%D
    • OCF YoY201.54%A
  • Operating ScoreD
    • Turnover0.36D
  • Debt ScoreA
    • Gearing Ratio17.97%A

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Prenetics Launches Major Warrant Exchange to Cut Dilution and Simplify Capital Structure

    Prenetics Global Limited announced a warrant exchange program, swapping Class A and B warrants for new Class C warrants to reduce dilution and simplify its capital structure. The exchange, supported by major shareholders, aims to cut the warrant overhang by 42% and improve the company's long-term dilution profile. The move is not linked to new financing, and Prenetics has no immediate plans for additional capital raising. Analysts rate the stock as Hold with a $14.00 target, noting profitability challenges despite positive technical trends.

    Tip Ranks·
    US
    PRE
    -0.18%
    Tip Ranks·
    US
    PRE
    -0.18%

    Prenetics Global to Exchange About 83% of Outstanding Warrants

    Prenetics Global to Exchange About 83% of Outstanding Warrants

    marketscreener·
    US
    PRE
    -0.18%
    marketscreener·
    US
    PRE
    -0.18%

    Prenetics strengthens capital structure through warrant exchange agreements with holders.

    Prenetics has recently signed agreements with warrant holders to exchange warrants, aiming to reinforce its capital structure. This move will result in the conversion of a significant number of warrants, enhancing the financial stability of the company. The agreement involves the exchange of a substantial volume of warrants for equity, which is anticipated to have a positive impact on Prenetics' financial position and strategic growth.

    Unusual Whales·
    US
    PRE
    -0.18%
    Unusual Whales·
    US
    PRE
    -0.18%

    Prenetics Enters Into Warrant Exchange Agreements With Warrant Holders, Strengthening Capital Structure | PRE Stock News

    Prenetics Global Limited announced warrant exchange agreements with holders of 83.4% of its Class A and B warrants, aiming to simplify its capital structure and reduce future dilution. The exchange involves swapping Class A and B warrants for new Class C warrants with a lower exercise price and a two-year term. This move is expected to reduce outstanding warrants by up to 50%, improving long-term dilution profile and enhancing share investability. The exchange reflects strong investor support and confidence in Prenetics' revised structure.

    StockTitan·
    US
    PRE
    -0.18%
    StockTitan·
    US
    PRE
    -0.18%

    Prenetics Global (NASDAQ:PRE) Shares Up 3.2% - Here's What Happened

    Prenetics Global (NASDAQ:PRE) shares rose 3.2% to $16.49, with trading volume up 25%. Analysts have mixed ratings: Wall Street Zen upgraded to 'buy', Weiss Ratings maintained 'sell', and Cantor Fitzgerald raised the target price to $32.00. Prenetics reported Q3 earnings with a loss of $0.41 per share, beating estimates. Institutional investors increased their holdings. The company focuses on genomics-driven health sciences and early cancer detection technologies.

    Market Beat·
    US
    PRE
    -0.18%
    Market Beat·
    US
    PRE
    -0.18%
    Posts
    View More

    News verification $XTALPI(02228.HK) The news you mentioned is basically accurate. I have cross-verified it through multiple reliable sources (such as the company's official press releases, Yahoo Finan......

    $XTALPI(02228.HK) There was no fancy movement in pre-market today. Hehe, is the real MM here? Were the unserious ones fired a few days ago?

    In today’s pre-mkt summary for Subscribers: $Tesla(TSLA.US) China weekly insured registrations hit 17.3K, a YTD high as refreshed Model Y production ramps higher; TSLA Europe Feb sales decline of -4...

    © 2025 Longbridge｜Disclaimer